To examine the clinical significance of galectin-3 in lung cancer, immunohistochemical staining was conducted on tissue microarrays containing samples from 197 patients with lung cancer, including small cell and non-small cell lung cancer (Fig. 7). This evidence concerns the gene LGALS3 and lung carcinoma.